Dr. Habibeh Khoshbouei, Ph.D., Pharm.D. (USA)
Dr. Khoshbouei is an internationally renowned neuroscientist and based in the United States. She is a full Professor in the Department of Neuroscience (with Joint Appointment in Department of Psychiatry) at the University of Florida at Gainesville in the United States. Projects in her laboratory are focused on the identification of novel mechanisms involved in regulation of dopamine neurotransmission in the brain. In particular, Prof. Khoshbouei’s research group is interested in the regulation of dopamine transporter (DAT), an integral membrane protein vital for regulation of synaptic dopamine. Work in her laboratory is devoted to understanding the details of DAT regulation, trafficking, the pharmacological modulation of the transporter and how this is all integrated into the broader context of normal dopamine signaling and the pathogenesis of addiction, neurological and neuropsychiatric disorders. Dr. Khoshbouei has advised several graduate students and postdoctoral scientists. She has published numerous articles in neuroscience in the world’s leading journals and presented a number of invited talks at national and international meetings in neuroscience. In addition, she has been an invited reviewer of several international journals and on the proposal reviewing panel for the US National Institute of Health and other federal agencies.
Dr. Khoshbouei is an internationally renowned neuroscientist and based in the United States. She is a full Professor in the Department of Neuroscience (with Joint Appointment in Department of Psychiatry) at the University of Florida at Gainesville in the United States. Projects in her laboratory are focused on the identification of novel mechanisms involved in regulation of dopamine neurotransmission in the brain. In particular, Prof. Khoshbouei’s research group is interested in the regulation of dopamine transporter (DAT), an integral membrane protein vital for regulation of synaptic dopamine. Work in her laboratory is devoted to understanding the details of DAT regulation, trafficking, the pharmacological modulation of the transporter and how this is all integrated into the broader context of normal dopamine signaling and the pathogenesis of addiction, neurological and neuropsychiatric disorders. Dr. Khoshbouei has advised several graduate students and postdoctoral scientists. She has published numerous articles in neuroscience in the world’s leading journals and presented a number of invited talks at national and international meetings in neuroscience. In addition, she has been an invited reviewer of several international journals and on the proposal reviewing panel for the US National Institute of Health and other federal agencies.
